Exploring the heterogeneity of hepatic and pancreatic fat deposition in obesity: implications for metabolic health.
Humans
Male
Female
Obesity
/ metabolism
Retrospective Studies
Middle Aged
Adult
Insulin Resistance
Pancreas
/ metabolism
Liver
/ metabolism
Non-alcoholic Fatty Liver Disease
/ metabolism
Pancreatic Diseases
/ metabolism
Magnetic Resonance Imaging
Intra-Abdominal Fat
/ metabolism
Blood Glucose
/ metabolism
fat deposition heterogeneity
insulin resistance
non-alcoholic fatty liver disease
non-alcoholic fatty pancreas disease
obesity
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2024
2024
Historique:
received:
12
06
2024
accepted:
19
09
2024
medline:
23
10
2024
pubmed:
23
10
2024
entrez:
23
10
2024
Statut:
epublish
Résumé
This retrospective observational study investigates the heterogeneity of hepatic and pancreatic fat deposition and its implications for metabolic health in individuals with obesity. A total of 706 patients with obesity underwent an MRI to quantify liver and pancreatic fat. Patients were classified into four groups based on fat deposition: no fat (None), fatty pancreas only (NAFPD), fatty liver only (NAFLD), and both conditions (NAFLD+NAFPD). Biochemical profiles, insulin resistance (Homeostatic Model Assessment for Insulin Resistance, HOMA-IR), and β-cell function were analyzed. A series of multiple linear regressions were used to investigate the independent effects of characteristics on glucose, insulin, and C-peptide at 0h. Another multiple linear regression was performed to evaluate the effects of basic characteristics on average liver fat, mean pancreatic fat, and visceral fat. The majority (76.63%) exhibited both NAFLD and NAFPD, highlighting the heterogeneity of fat deposition among individuals with obesity. Groups with fatty liver displayed significantly higher fasting glucose, insulin, C-peptide, and HOMA-IR levels than those without fatty liver (P < 0.01). Fatty pancreas alone did not significantly influence these metabolic parameters (P > 0.05). This underscores the greater metabolic impact of hepatic fat compared to pancreatic fat. The study confirms the complex heterogeneity of fat deposition in obesity, with the fatty liver being a more influential factor in metabolic disturbances than the fatty pancreas. The prevalent co-occurrence of NAFLD and NAFPD in this population underscores the need for targeted management strategies focusing on hepatic fat reduction to mitigate metabolic risk.
Identifiants
pubmed: 39439559
doi: 10.3389/fendo.2024.1447750
pmc: PMC11493592
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1447750Informations de copyright
Copyright © 2024 Deng, Li, Chen, Wang, Sun, Tang, Luo, Zhang, Xu and Dai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.